CYP19A1 and diabetes mellitus: A higher proportion of statin users than nonusers were also more likely to have used other medications (beta blockers, ACEIs, ARBs, diuretics, metformin, and aromatase inhibitors, but not tamoxifen) and to have had documented comorbidities (any cardiac condition, diabetes, stroke, and renal disease) (p < 0.05 for all differences).